MDI Therapeutics

Novi, United States

MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.

$9.0M raised

Mar 2022

Series A

Biotechnology Pharmaceutical Therapeutics

Top Investors

Juvenescence

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MDI Therapeutics

How much funding has MDI Therapeutics raised?

MDI Therapeutics has raised $9.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are MDI Therapeutics's investors?

MDI Therapeutics's investors include Juvenescence.

Where is MDI Therapeutics headquartered?

MDI Therapeutics is headquartered in Novi, United States.

What does MDI Therapeutics do?

MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.

What stage is MDI Therapeutics at?

MDI Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2022.

MLA

"MDI Therapeutics — Funding & Investors." VCBacked, March 2, 2022, https://www.vcbacked.co/company/mdi-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2022). MDI Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/mdi-therapeutics

Wikipedia (cite web)

{{cite web |title=MDI Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mdi-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K